Gumarontinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gumarontinib, covering 2024-06-11 to 2024-06-11. Get the full timeline:
Most recent: Clinical Trial Update: Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer. [Phase 2]